Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P63252: Variant p.Asp172Asn

Inward rectifier potassium channel 2
Gene: KCNJ2
Feedback?
Variant information Variant position: help 172 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Aspartate (D) to Asparagine (N) at position 172 (D172N, p.Asp172Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In SQT3; gain of function. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 172 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 427 The length of the canonical sequence.
Location on the sequence: help DECPIAVFMVVFQSIVGCII D AFIIGAVMAKMAKPKKRNET The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         DECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

                              DECPVAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

Rhesus macaque                DECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

Mouse                         DECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

Rat                           DECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

Pig                           DECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

Bovine                        DECPVAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

Rabbit                        DECPVAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

Chicken                       DECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMAKPKKRNET

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 427 Inward rectifier potassium channel 2
Transmembrane 157 – 178 Helical; Name=M2
Site 172 – 172 Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium



Literature citations
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.
Priori S.G.; Pandit S.V.; Rivolta I.; Berenfeld O.; Ronchetti E.; Dhamoon A.; Napolitano C.; Anumonwo J.; di Barletta M.R.; Gudapakkam S.; Bosi G.; Stramba-Badiale M.; Jalife J.;
Circ. Res. 96:800-807(2005)
Cited for: VARIANT SQT3 ASN-172; CHARACTERIZATION OF VARIANT SQT3 ASN-172;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.